These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24451644)

  • 41. Function of ubiquitin (Ub) specific protease 15 (USP15) in HIV-1 replication and viral protein degradation.
    Pyeon D; Timani KA; Gulraiz F; He JJ; Park IW
    Virus Res; 2016 Sep; 223():161-9. PubMed ID: 27460547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 Nef and host proteome analysis: Current perspective.
    Saxena R; Vekariya U; Tripathi R
    Life Sci; 2019 Feb; 219():322-328. PubMed ID: 30664855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.
    Watkins RL; Foster JL; Garcia JV
    Retrovirology; 2015 Jul; 12():61. PubMed ID: 26169178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1 Nef: at the crossroads.
    Foster JL; Garcia JV
    Retrovirology; 2008 Sep; 5():84. PubMed ID: 18808677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Novel Subcellular Localization and Trafficking of HIV-1 Nef Variants from Reference Strains G (F1.93.HH8793) and H (BE.93.VI997).
    Van Nynatten LR; Johnson AL; Dirk BS; Pawlak EN; Jacob RA; Haeryfar SMM; Dikeakos JD
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30217018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV-1 nef protein visits B-cells via macrophage nanotubes: a mechanism for AIDS-related lymphoma pathogenesis?
    Lamers SL; Fogel GB; Huysentruyt LC; McGrath MS
    Curr HIV Res; 2010 Dec; 8(8):638-40. PubMed ID: 21067513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV-1 Nef dimers short-circuit immune receptor signaling by activating Tec-family kinases at the host cell membrane.
    Li WF; Aryal M; Shu ST; Smithgall TE
    J Biol Chem; 2020 Apr; 295(15):5163-5174. PubMed ID: 32144207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
    Matusali G; Potestà M; Santoni A; Cerboni C; Doria M
    J Virol; 2012 Apr; 86(8):4496-504. PubMed ID: 22301152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell-based Fluorescence Complementation Reveals a Role for HIV-1 Nef Protein Dimerization in AP-2 Adaptor Recruitment and CD4 Co-receptor Down-regulation.
    Shu ST; Emert-Sedlak LA; Smithgall TE
    J Biol Chem; 2017 Feb; 292(7):2670-2678. PubMed ID: 28031466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
    Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic targeting of interactions between Nef and host cell proteins.
    Saksela K
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Dec; 4(4):315-9. PubMed ID: 15578982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection.
    Buffalo CZ; Iwamoto Y; Hurley JH; Ren X
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modelling interaction between HIV-1 Nef and calnexin.
    Adzhubei AA; Anashkina AA; Tkachev YV; Kravatsky YV; Pushkarsky T; Kulkarni A; Makarov AA; Bukrinsky MI
    AIDS; 2018 Sep; 32(15):2103-2111. PubMed ID: 30005006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.
    Raymond AD; Diaz P; Chevelon S; Agudelo M; Yndart-Arias A; Ding H; Kaushik A; Jayant RD; Nikkhah-Moshaie R; Roy U; Pilakka-Kanthikeel S; Nair MP
    J Neurovirol; 2016 Apr; 22(2):129-39. PubMed ID: 26631079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous assessment of CD4 and MHC-I downregulation by Nef primary isolates in the context of infection.
    Ali A; Realegeno S; Yang OO; Lewis MJ
    J Virol Methods; 2009 Nov; 161(2):297-304. PubMed ID: 19643141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of Nef-mediated CD3 down-regulation in the HIV-1 lineage increases viral infectivity and spread.
    Mesner D; Hotter D; Kirchhoff F; Jolly C
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7382-7391. PubMed ID: 32179688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a novel binding site between HIV type 1 Nef C-terminal flexible loop and AP2 required for Nef-mediated CD4 downregulation.
    Jin YJ; Cai CY; Mezei M; Ohlmeyer M; Sanchez R; Burakoff SJ
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):725-31. PubMed ID: 23151229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.
    Kumar A; Abbas W; Colin L; Khan KA; Bouchat S; Varin A; Larbi A; Gatot JS; Kabeya K; Vanhulle C; Delacourt N; Pasquereau S; Coquard L; Borch A; König R; Clumeck N; De Wit S; Rohr O; Rouzioux C; Fulop T; Van Lint C; Herbein G
    Sci Rep; 2016 Apr; 6():24090. PubMed ID: 27076174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody.
    Bouchet J; Basmaciogullari SE; Chrobak P; Stolp B; Bouchard N; Fackler OT; Chames P; Jolicoeur P; Benichou S; Baty D
    Blood; 2011 Mar; 117(13):3559-68. PubMed ID: 21292773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.